Announcement of $10 million grant for the Frontier study at St. Michael's Hospital, which will test the neuroprotectant stroke drug N1-A developed by Dr. Mike Tymianski, Head of Neurosurgery and Senior Scientist at TWRI. Photo credit: St. Michael's Hospital
Stroke is one of the leading causes of death and disability world-wide. Dr. Tymianski has dedicated two decades to beating this disease and has developed the only drug in the world aimed at protecting the brain from stroke. Tymianski's stroke drug NA-1 is now in a Phase III trial, which will show if the drug is effective at reducing the damage of stroke. A new $10 million grant will fund the FRONTIER trial involves paramedics administering the drug to patients who have suffered a stroke.
Related Links
